SF
Stephen Feider sold $153K of BBNX stock
Stephen Feider, Chief Financial Officer of Beta Bionics, Inc. (BBNX), sold 8,874 shares of BBNX stock worth $153K, per an SEC Form 4 filed Nov 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 11, 2026, 2 days before it was made public.
BBNX has moved -7.8% since the trade date, from $17.81 to $16.42 (Nov 13, 2026 close).
- Traded
- Nov 11, 2026
- Disclosed
- Nov 13, 2026
- Filing delay
- 2 days
- Price since
- -7.8%
- Role
- Chief Financial Officer
- Source
- SEC Form 4